{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T07:32:33Z","timestamp":1725867153409},"publisher-location":"Cham","reference-count":68,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319435787"},{"type":"electronic","value":"9783319435800"}],"license":[{"start":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T00:00:00Z","timestamp":1475539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-43580-0_21","type":"book-chapter","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T17:30:12Z","timestamp":1475515812000},"page":"257-267","source":"Crossref","is-referenced-by-count":4,"title":["Vaccination Expectations in HNSCC"],"prefix":"10.1007","author":[{"given":"Stina","family":"Syrj\u00e4nen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Rautava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,4]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Aboqunrin S, Di Tanna GL, Keeping S, Carroll S, Iheanacho I (2014) Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis. BMC Cancer 14:968","key":"21_CR1","DOI":"10.1186\/1471-2407-14-968"},{"issue":"8","key":"21_CR2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.oraloncology.2015.05.007","volume":"51","author":"KS Anderson","year":"2015","unstructured":"Anderson KS, Gerber JE, D\u2019Souza G, Pai SI, Cheng JN, Alam R, Kesiraju S, Chowell D, Gross ND, Haddad R, Gillison ML, Posner M (2015) Biologic predictors of serologic responses to HPV in oropharyngeal cancer: the HOTSPOT study. Oral Oncol 51(8):751\u2013758","journal-title":"Oral Oncol"},{"doi-asserted-by":"crossref","unstructured":"Beachler DC, Kreimer AR, Schiffman M, Herrero R, Wacholder R, Rodriguez AC, Lowy DR, Porras C, Schiller JT, Quint Q, Jimenez S, Safaeian M, Struijk L, Schussler J, HIlderheim A, Gonzalez P, Costa Rica HPV Vaccine Trial (CVT) Group (2015) Multisite HPV16\/18 vaccine efficacy against cervical, anal and oral HPV infection. J Natl Cancer Inst 108(1)","key":"21_CR3","DOI":"10.1093\/jnci\/djv302"},{"doi-asserted-by":"crossref","unstructured":"Brotherton M, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S. (2016) Eurogin roadmap 2015: how has HPV knowledge changed our practice: vaccines. Int J Cancer (Epub ahead of print)","key":"21_CR4","DOI":"10.1002\/ijc.30063"},{"issue":"3","key":"21_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/CDLI.10.3.431-438.2003","volume":"10","author":"JE Cameron","year":"2003","unstructured":"Cameron JE, Snowhite IV, Chaturvedi AK, Hagensee ME (2003) Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin Diagn Lab Immunol 10(3):431\u2013438","journal-title":"Clin Diagn Lab Immunol"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","volume":"29","author":"AK Chaturvedi","year":"2011","unstructured":"Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Alterkruse S, Anderson WF, Rosenberg PS, Gillison ML (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294\u20134301","journal-title":"J Clin Oncol"},{"issue":"15","key":"21_CR7","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4236\/jct.2015.615140","volume":"6","author":"C Chisanga","year":"2015","unstructured":"Chisanga C, Eggert D, Mitchell CD, Wood C, Angeletti PC (2015) Evidence for placental HPV infection in both HIV positive and negative women. J Cancer Ther 6(15):1276\u20131289","journal-title":"J Cancer Ther"},{"unstructured":"Chung CH, Bagheri A, D\u2019Souza G (2013) Epidemiology of oral human papillomavirus infection. Oral Oncol S1368-8375(13):00685-4","key":"21_CR8"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/OLQ.0b013e318269d098","volume":"39","author":"ZR Edelstein","year":"2012","unstructured":"Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, Stern ME et al (2012) Rates and determinants of oral human papillomavirus infection in young men. Sex Trans Dis 39:860\u2013867","journal-title":"Sex Trans Dis"},{"doi-asserted-by":"crossref","unstructured":"Einstein MH, Takacs P, Chatterjee A, Sperling RS, Chakhtoura N, Blatter MM, Lalezari J, David MP, Lin L, Struyf F, Dubin G; HPV-101 Study Group (2014) Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine and HPV-6\/11\/16\/18 vaccine in healthy women aged 18\u201345\u00a0years: end-of-study analysis of a phase III randomized trial. Human Vaccin Immunother 10(12):3435\u20133445","key":"21_CR10","DOI":"10.4161\/hv.36121"},{"key":"21_CR11","first-page":"26","volume":"107","author":"A Fruscalzo","year":"2016","unstructured":"Fruscalzo A, Londero AP, Bertozzi S, Lelle RJ (2016) Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development. Minerva Med 107:26\u201338","journal-title":"Minerva Med"},{"doi-asserted-by":"crossref","unstructured":"Gama RR, Carvalho AL, Filho AL, Scorsato AP, Lopez RV, Rautava J, Syrj\u00e4nen S, Syrj\u00e4nen K (2016) Detection of human papillomavirus in laryngeal squamous cell carcinoma: systematic review and meta-analysis. Laryngoscope 126(4):885\u2013893","key":"21_CR12","DOI":"10.1002\/lary.25738"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","volume":"70","author":"SM Garland","year":"2010","unstructured":"Garland SM, Smith JS (2010) Human papillomavirus vaccines: current status and future prospects. Drugs 70:1079\u20131098","journal-title":"Drugs"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","volume":"307","author":"ML Gillison","year":"2012","unstructured":"Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK (2012) Prevalence of oral HPV infection in the United States, 2009\u20132010. JAMA 307:693\u2013703","journal-title":"JAMA"},{"issue":"5","key":"21_CR15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","volume":"364","author":"AR Giuliano","year":"2011","unstructured":"Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D (2011) Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 364(5):401\u2013411","journal-title":"N Engl J Med"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1016\/j.vaccine.2013.06.057","volume":"31","author":"SE Goldstone","year":"2013","unstructured":"Goldstone SE, Jessen H, Palefsky JM, Giuliano AR, Moreira ED Jr, Vardas E, Aranda C, Hillman RJ, Ferris DG, Coutlee F, Marshall JB, Vuocolo S, Haupt RM, Guris D, Garner E (2013) Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males. Vaccine 31:3849\u20133855","journal-title":"Vaccine"},{"doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves AK1, Giraldo P, Barros-Mazon S, Gondo ML, Amaral RL, Jacyntho C (2006) Secretory immunoglobulin A in saliva of women with oral and genital HPV infection. Eur J Obstet Gynecol Reprod Biol 124(2):227\u2013231","key":"21_CR17","DOI":"10.1016\/j.ejogrb.2005.06.028"},{"issue":"4","key":"21_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lary.25767","volume":"126","author":"Z Gooi","year":"2016","unstructured":"Gooi Z, Chan JY, Fakhry C (2016) The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope 126(4):894\u2013900","journal-title":"Laryngoscope"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/cncr.29111","volume":"121","author":"DM Graham","year":"2015","unstructured":"Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS (2015) A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer 121:1785\u20131792","journal-title":"Cancer"},{"issue":"1","key":"21_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365548.2014.964764","volume":"47","author":"N Grun","year":"2015","unstructured":"Grun N, \u00c5hrlund-Richter A, Franzen J, Mirzaie L, Marions L, Ramqvist T, Dalianis T (2015) Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination. Infect Dis 47(1):57\u201361","journal-title":"Infect Dis"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2015.462","volume":"114","author":"A Handisurya","year":"2016","unstructured":"Handisurya A, Schellenbacher C, Haitel A, Senger T, Kirnbauer R (2016) Human papillomavirus vaccination induces neutralizing antibodies in oral mucosal fluids. Br J Cancer 114:409\u2013416","journal-title":"Br J Cancer"},{"doi-asserted-by":"crossref","unstructured":"Hardefeldt HA, Cox MR, Eslick GD (2014) Association between human papillomavirus (HPV) and oesophageal squamous cell carcinoma: a meta-analysis. Epidemiol Infect 124(6):1119\u20131137","key":"21_CR22","DOI":"10.1017\/S0950268814000016"},{"issue":"1","key":"21_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jcv.2014.06.012","volume":"61","author":"A Haukioja","year":"2014","unstructured":"Haukioja A, Asunta M, S\u00f6derling E, Syrj\u00e4nen S (2014) Persistent oral human papillomavirus infection is associated with smoking and elevated salivary immunoglobulin G concentration. J Clin Virol 61(1):101\u2013106","journal-title":"J Clin Virol"},{"doi-asserted-by":"crossref","unstructured":"Hermann JS, Weckx LY, Monteiro NJ, Santor GF Jr, Campos PAC, Nagata PSS (2016) Effectiveness of the human papillomavirus (types 6, 11, 16 and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis. Int J Pediatr Otorhinolaryngol 83:94\u201398","key":"21_CR24","DOI":"10.1016\/j.ijporl.2016.01.032"},{"doi-asserted-by":"crossref","unstructured":"Herrero R, Quint W, HIldesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR, CVT Vaccine Group (2013) Reduced prevalence of oral human papillomavirus (HPV) 4\u00a0years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS ONE 8(7):e68329","key":"21_CR25","DOI":"10.1371\/journal.pone.0068329"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00405-014-3143-y","volume":"271","author":"I Hocevar-Boltezar","year":"2014","unstructured":"Hocevar-Boltezar I, Maticic M, Sereq-Bahar M, Gale N, Poljak M, Kocjan B, Zargi M (2014) Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 271:3255\u20133262","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"21_CR27","first-page":"61","volume":"2","author":"TJ Kemp","year":"2012","unstructured":"Kemp TJ, Safaeian M, Miner S, Williams MC, Rodrigues AC, Herrero R, Hildesheim A, Pinto AL (2012) Oral immunoglobulin levels are not a good surrogate for cervical immunoglobulin levels. Front Oncol 2:61","journal-title":"Front Oncol"},{"issue":"6","key":"21_CR28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.eururo.2012.06.045","volume":"62","author":"K Kero","year":"2012","unstructured":"Kero K, Rautava J, Syrj\u00e4nen K, Grenman S, Syrj\u00e4nen S (2012) Oral mucosa as a reservoir of human papillomavirus: point prevalence, genotype distribution, and incident infections among males in a 7-year prospective study. Eur Urol 62(6):1063\u20131070","journal-title":"Eur Urol"},{"issue":"1","key":"21_CR29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10096-013-1938-1","volume":"33","author":"K Kero","year":"2014","unstructured":"Kero K, Rautava J, Syrj\u00e4nen K, Willberg J, Grenman S, Syrj\u00e4nen S (2014) Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis 33(1):123\u2013133","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"21_CR30","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.4161\/hv.25272","volume":"9","author":"G Kichaev","year":"2013","unstructured":"Kichaev G, Mendoza JM, Amante D, Smith TR, McCoy JR, Sardesai NY, Broderick KE (2013) Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses. Hum Vaccin Immunother 9(10):2014\u20132018","journal-title":"Hum Vaccin Immunother"},{"issue":"24","key":"21_CR31","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","volume":"89","author":"R Kirnbauer","year":"1992","unstructured":"Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 89(24):12180\u201312184","journal-title":"Proc Natl Acad Sci USA"},{"doi-asserted-by":"crossref","unstructured":"Koskimaa HM, Waterboer T, Pawlita M, Grenman S, Syrj\u00e4nen K, Syrj\u00e4nen S (2012) Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes. J Pediatr 160(5):837\u2013843","key":"21_CR001","DOI":"10.1016\/j.jpeds.2011.10.027"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-12-44","volume":"12","author":"HM Koskimaa","year":"2014","unstructured":"Koskimaa HM, Paaso AE, Welters MJ, Grenman SE, Syrj\u00e4nen KJ, van der Burg SH, Syrj\u00e4nen SM (2014) J Transl Med 12:44","journal-title":"J Transl Med"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12967-015-0733-4","volume":"13","author":"HM Koskimaa","year":"2015","unstructured":"Koskimaa HM, Paaso A, Welters MJ, Grenman S, Syrj\u00e4nen K, van der Burg SH, Syrj\u00e4nen S (2015) Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negative. J Transl Med 13:370","journal-title":"J Transl Med"},{"issue":"21","key":"21_CR34","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","volume":"31","author":"AR Kreimer","year":"2013","unstructured":"Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, Tjonneland A, Overvad K, Quiros JR, Gonzalez CA, Sanchez MJ, Larranaga N, Navarro C, Barricarte A, Travis RC, Khaw KT, Wareham N, Trichopoulos A, Lagiou P, Trichopoulos D, Peeters PH, Panico S, Masala G, Grioni S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Laurell G, Hallmans G, Manjer J, Ekstr\u00f6m J, Skele G, Lund E, Weiderpass E, Ferrari P, Byrnes G, Romineu I, Riboli E, Hildesheim A, Boeing H, Pawlita M, Brennan P (2013) Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 31(21):2708\u20132715","journal-title":"J Clin Oncol"},{"doi-asserted-by":"crossref","unstructured":"Lang Kuhs KA, Pawlita M, Gibson SP, Schmitt NC, Trivedi S, Argiris A, Kreimer AR, Ferris RL, Waterboer T (2016) Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Cancer Epidemiol 42:46\u201352","key":"21_CR35","DOI":"10.1016\/j.canep.2016.03.003"},{"issue":"4","key":"21_CR36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humrep\/det453","volume":"29","author":"C Laprise","year":"2014","unstructured":"Laprise C, Trottier H, Monnier P, Coutlee F, Mayrand MH (2014) Prevalence of human papillomavirus in semen: a systematic review and meta-analysis. Hum Reprod 29(4):640\u2013651","journal-title":"Hum Reprod"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/hum.2012.037","volume":"24","author":"G Lescaille","year":"2013","unstructured":"Lescaille G, Pitoiset F, Macedo R, Baillou C, Huret C, Klatzmann D et al (2013) Efficacy of DNA vaccines forming E7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers. Hum Gen Ther 24:533\u2013544","journal-title":"Hum Gen Ther"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1158\/1055-9965.EPI-10-1160","volume":"20","author":"B Lu","year":"2011","unstructured":"Lu B, Viscidi RP, Lee JH, Wu Y, Villa LL, Lazcano-Ponce E, da Silva RJ, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen M, Papenfuss M, Stockwell HG, Giuliano AR (2011) Human papillomavirus (HPV) 6, 11, 16 and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV infection in men study (HIM study). Cancer Epidemiol Biomark Prev 20:990\u20131002","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"21_CR39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","volume":"73","author":"S Lyford-Pike","year":"2013","unstructured":"Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topallan SL, Pardoll DM, Pai SI (2013) Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res 73(6):1733\u20131741","journal-title":"Cancer Res"},{"issue":"10","key":"21_CR40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","volume":"12","author":"T Malagon","year":"2012","unstructured":"Malagon T, Drolet M, Bolly MC, Franco EL, Jit M, Brisson J, Brisson M (2012) Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancer Infect Dis 12(10):781\u2013789","journal-title":"Lancer Infect Dis"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2334-6-95","volume":"6","author":"DJ Marais","year":"2006","unstructured":"Marais DJ, Sampson C, Jeftha A, Dhaya D, Passmore JA, Denny L, Rybicki EP, Van Der Walt E, Stephen LX, Williamson AL (2006) More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 6:95","journal-title":"BMC Infect Dis"},{"issue":"3","key":"21_CR42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mayocp.2015.12.017","volume":"91","author":"S Marur","year":"2016","unstructured":"Marur S, Forastiere AA (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91(3):386\u2013396","journal-title":"Mayo Clin Proc"},{"doi-asserted-by":"crossref","unstructured":"Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S (2013) Head Neck 35(5):747\u2013755","key":"21_CR43","DOI":"10.1002\/hed.22015"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1158\/1535-7163.MCT-14-1015","volume":"14","author":"M Mondini","year":"2015","unstructured":"Mondini M, Nizard M, Tran T, Mauge L, Loi M, Clemenson C, Dugue D, Maroun P, Louvet E, Adam J, Badoual C, Helley D, Dransart E, Johannes L, Vozenin MC, Perfettini JL, Tartour E, Deutsch E (2015) Synergy of radiotherapy and a cancer vaccine for the treatment of HPV-associated head and neck cancer. Mol Cancer Ther 14:1336\u20131345","journal-title":"Mol Cancer Ther"},{"issue":"25","key":"21_CR45","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","volume":"21","author":"SE Olsson","year":"2007","unstructured":"Olsson SE, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen OE, Hoye J, Steinwall M, Riis-Johannssen G, Andersson-Ellstrom A, Elfgren K, von Krogh G, Lehtinen M, Paavonen J, Tamms GM, Giacoletti K, Lupinacci L, Esser MT, Vuocolo SC, Saah AJ, Barr E (2007) Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18 virus-like particle (VLP) vaccine. Vaccine 21(25):4931\u20134939","journal-title":"Vaccine"},{"issue":"17","key":"21_CR46","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","volume":"365","author":"JM Palefsky","year":"2011","unstructured":"Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576\u20131585","journal-title":"N Engl J Med"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/jmv.20901","volume":"79","author":"JA Passmore","year":"2007","unstructured":"Passmore JA, Marais DJ, Sampson C, Allan B, Parker N, Milner M, Denny L, Williamson AL (2007) Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. J Med Virol 79:1375\u20131380","journal-title":"J Med Virol"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/OLQ.0b013e31824f1c65","volume":"39","author":"RK Pickard","year":"2012","unstructured":"Pickard RK, Xiao W, Broutian TR, He X, Gillison ML (2012) The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 39:559\u2013566","journal-title":"Sex Transm Dis"},{"issue":"8","key":"21_CR49","doi-asserted-by":"crossref","first-page":"e42171","DOI":"10.1371\/journal.pone.0042171","volume":"7","author":"J Rautava","year":"2012","unstructured":"Rautava J, Willberg J, Louvanto K, Wideman L, Syrj\u00e4nen K, Grenman S, Syrj\u00e4nen S (2012a) Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS ONE 7(8):e42171","journal-title":"PLoS ONE"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcv.2011.11.005","volume":"53","author":"J Rautava","year":"2012","unstructured":"Rautava J, Kuuskoski J, Syrj\u00e4nen K, Grenman R, Syrj\u00e4nen S (2012b) HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas. J Clin Virol 53:116\u2013120","journal-title":"J Clin Virol"},{"doi-asserted-by":"crossref","unstructured":"Reuschenbach M, Pauligk C, Karbach J, Rafiyan MR, Kloor M, Prigge ES, Sauer M, Al-Batran SE, Kaufmann AM, Schneider A, J\u00e4ger E, von Knebel Doeberitz M (2016) A phase 1\/2a study to test the safety and immunogenicity of a p 16INK4a peptide vaccine in patients with advanced human papillomavirus-associated cancers. Cancer 112(9):1425\u20131433","key":"21_CR51","DOI":"10.1002\/cncr.29925"},{"issue":"11","key":"21_CR52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1258\/0956462042395122","volume":"15","author":"MA Rintala","year":"2004","unstructured":"Rintala MA, Grenman SE, P\u00f6ll\u00e4nen PP, Suominen JJ, Syrj\u00e4nen SM (2004) Detection of high-risk HPV DNA in semen and its association with the quality of semen. Int J STD AIDS 15(11):740\u2013743","journal-title":"Int J STD AIDS"},{"issue":"12","key":"21_CR53","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1086\/498114","volume":"41","author":"MA Rintala","year":"2005","unstructured":"Rintala MA, Grenman SE, J\u00e4rvenkyl\u00e4 ME, Syrj\u00e4nen KJ, Syrj\u00e4nen SM (2005) High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3\u00a0years of life: experience from the Finnish HPV Family Study. Clin Infect Dis 41(12):1728\u20131733","journal-title":"Clin Infect Dis"},{"doi-asserted-by":"crossref","unstructured":"Roteli-Martins C, NAud P, De Borba P, Teixeira J, De Carvalho N, Zahaf T et al (2012) Sustained immunogenicity and efficacy of the HPV-16\/18 As04-adjuvant vaccine: up to 8.4\u00a0years of follow-up. Hum Vaccin Immunother 8(3):1","key":"21_CR54","DOI":"10.4161\/hv.18865"},{"issue":"11","key":"21_CR55","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/00016340802468308","volume":"87","author":"ME Sarkola","year":"2008","unstructured":"Sarkola ME, Grenman SE, Rintala MA, Syrj\u00e4nen KJ, Syrj\u00e4nen SM (2008) Human papillomavirus in the placenta and umbilical cord blood. Acta Obstet Gynecol Scand 87(11):1181\u20131188","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"30","key":"21_CR56","first-page":"5","volume":"20","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 20(30):5","journal-title":"Vaccine"},{"doi-asserted-by":"crossref","unstructured":"Shaikh MH, McMillan NA, Johnson NW (2015) HPV-associated head and neck cancers in the Asia Pacific: a critical literature review and meta-analysis. Cancer Epidemiol 39(6):923\u2013938","key":"21_CR57","DOI":"10.1016\/j.canep.2015.09.013"},{"key":"21_CR58","doi-asserted-by":"crossref","first-page":"126417","DOI":"10.1155\/2015\/126417","volume":"2015","author":"M Skoczynski","year":"2015","unstructured":"Skoczynski M, Gozdzicka-Jozefiak A, Kwasniewska A (2015) The prevalence of human papillomavirus between the neonates and their mothers. Biomed Res Int 2015:126417","journal-title":"Biomed Res Int"},{"key":"21_CR59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/INF.0b013e318124a4ae","volume":"26","author":"EM Smith","year":"2007","unstructured":"Smith EM, Swarnavel S, Ritchie JM, Wang D, Haugen TH, Turek LR (2007) Prevalence of human papillomavirus in the oral cavity\/oropharynx in large population of children and adolescents. Pediatr Infect Dis J 26:836\u2013840","journal-title":"Pediatr Infect Dis J"},{"key":"21_CR60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/moe.2001.108797","volume":"91","author":"KF Summersgill","year":"2001","unstructured":"Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP (2001) Human papillomavirus in the oral cavities of children and adolescents. Oral Sug Oral Med Oral Pathol Oral Radiol Endod 91:62\u201369","journal-title":"Oral Sug Oral Med Oral Pathol Oral Radiol Endod"},{"doi-asserted-by":"crossref","unstructured":"Syrj\u00e4nen K (2013) Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: systematic review and meta-analysis. Scand J Infect Dis 45:1\u201318","key":"21_CR61","DOI":"10.3109\/00365548.2012.702281"},{"doi-asserted-by":"crossref","unstructured":"Syrj\u00e4nen K, Syrj\u00e4nen S (2013) Detection of human papillomavirus (HPV) in sinonasal carcinoma: systematic review and meta-analysis. Hum Pathol 44:983\u2013991","key":"21_CR62","DOI":"10.1016\/j.humpath.2012.08.017"},{"unstructured":"Syrj\u00e4nen S, Rintala M, Willberg J, Rautava J, Koskimaa H, Paaso A, Kero K, Louvanto K, Syrj\u00e4nen K, Grenman S. Oral HPV infections in nonsexually active children six-year incidence, clearance and persistence. Submitted","key":"21_CR65"},{"doi-asserted-by":"crossref","unstructured":"Takes RP, Wierzbicka M, D\u2019Souza G, Jackowska J, Silver CE, Rodrigo JP, Dikkers FG, Olsen KD, Rinaldo A, Brakenhoff RH, Ferlito A (2015) HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs? Oral Oncol 51(21):1057\u20131060","key":"21_CR63","DOI":"10.1016\/j.oraloncology.2015.10.011"},{"doi-asserted-by":"crossref","unstructured":"Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G (2008) HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988\u20132007). Ann Oncol 19(10):1681\u20131690","key":"21_CR64","DOI":"10.1093\/annonc\/mdn372"},{"key":"21_CR66","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00262-014-1640-x","volume":"64","author":"DP Zandberg","year":"2015","unstructured":"Zandberg DP, Rollins S, Goloubeva O, Morales RE, Tan M, Taylor R, Wolf JS, Schumaker LM, Cullen KJ, Zimrin A, Ord R, Lubek JE, Suntharalingam M (2015) A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent\/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN). Cancer Immunol Immunother 64:367\u2013379","journal-title":"Cancer Immunol Immunother"},{"doi-asserted-by":"crossref","unstructured":"Zhang SK, Guo LW, Chen Q, Zhang M, Liu SZ, Quan PL, Lu JB, Sun XB (2014) Prevalence of human papillomavirus 16 in esophageal cancer among the Chinese population: a systematic review and meta-analysis. Asian Pac J Cancer Prev 15(23):10143\u201310149","key":"21_CR67","DOI":"10.7314\/APJCP.2014.15.23.10143"}],"container-title":["Recent Results in Cancer Research","HPV Infection in Head and Neck Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-43580-0_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T11:21:54Z","timestamp":1601119314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-43580-0_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"ISBN":["9783319435787","9783319435800"],"references-count":68,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-43580-0_21","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"type":"print","value":"0080-0015"},{"type":"electronic","value":"2197-6767"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}